D. Darryl Hudson (born 1982 in Lethbridge, Alberta) is a Canadian scientist, inventor, serial entrepreneur and musician. Hudson was awarded the Alexander Graham Bell Canada graduate scholarship and the first MITACS Industrial post-doctoral fellowship award and received his PhD in molecular biology and genetics from Guelph University in 2010 specializing in genetic engineering of crop plants. Dr. Hudson performs studies and clinical research on psilocybin (magic mushrooms), and is the co-founder of GoodCap Pharmaceuticals, a psychedelic pharmaceutical company based in Canada. [1]

Hudson is an expert in plants and fungi and has contributed to groundbreaking studies in the psychedelic field and of the genetics of Cannabis.[2][3] Actively breeding hemp crops in Canada and abroad,[4][5] Hudson has pioneered plant and natural extraction protocols focusing on efficient and safe methods for removal and separation of medical molecules.[6]

Hudson has been active in studying post traumatic stress disorder (PTSD) specifically working with military veterans to develop both medications and protocols.[7]< Hudson spoke to the US Senate, prior to the groundbreaking legislation that allowed US veterans to receive recommendations for medical marijuana.[8][9] He continues to speak at many international conferences.[10][11][12]

Hudson is also co-author of numerous peer-reviewed scientific publications and research articles, on plant biology, plant genetics, DNA repair, epigenetics, inflammation, and cancer.[13]

References

  1. ↑ Pharmaceuticals https://goodcap.com=GoodCap Pharmaceuticals. {{cite web}}: Check |url= value (help); Missing or empty |title= (help)
  2. ↑ "Compositions for reducing inflammation to improve or maintain mental or physical health". Google patents. Retrieved 6 September 2023.
  3. ↑ Sawler, Jason; Stout, Jake M.; Gardner, Kyle M.; Hudson, Darryl; Vidmar, John; Butler, Laura; Page, Jonathan E.; Myles, Sean (2015). "The Genetic Structure of Marijuana and Hemp". PLOS ONE. 10 (8): e0133292. Bibcode:2015PLoSO..1033292S. doi:10.1371/journal.pone.0133292. PMC 4550350. PMID 26308334.
  4. ↑ "What We Do Implant Biotech". implantbiotech.com. Archived from the original on March 17, 2018. Retrieved March 21, 2018.
  5. ↑ "Dr. Darryl Hudson Pharmacielo". pharmacielo.com. Archived from the original on August 12, 2018. Retrieved March 21, 2018.
  6. ↑ "Daryl Hudson Ph.D." bloomberg.com. Retrieved March 21, 2018.
  7. ↑ "Medical pot works in the battle against PTSD, vets say". thestar.com. 23 April 2017. Retrieved March 21, 2018.
  8. ↑ "Forum on the Hill About Medical Cannabis for Veterans: "To Our Commander in Chief – Are You Listening?"". cannabisbusinessexecutive.com. 19 September 2017. Retrieved March 21, 2018.
  9. ↑ "Senate panel votes to end VA ban on medical marijuana". thehill.com. 21 May 2015. Retrieved March 21, 2018.
  10. ↑ "ICBC Berlin 2017 - Dr. Darryl Hudson, Alan Dronkers & Dr. Reggie Gaudino". youtube.com. Retrieved March 21, 2018.
  11. ↑ "Champs Canada Marijuana Expo: Interview with Darryl Hudson of Peace Naturals". youtube.com. Retrieved March 21, 2018.
  12. ↑ "Medical Professionals Are Taking Cannabis Serious, Here's the Proof". takomawellness.com. Archived from the original on March 17, 2018. Retrieved March 21, 2018.
  13. ↑ "Adaptation of Arabidopsis to nitrogen limitation involves induction of anthocyanin synthesis which is controlled by the NLA gene". researchgate.net. Retrieved March 21, 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.